136 related articles for article (PubMed ID: 21266630)
1. The First Description of Docetaxel-Induced Recall Inflammatory Skin Reaction After Previous Drug Extravasation.
Kramer F; Schippert C; Rinnau F; Hillemanns P; Park-Simon TW
Ann Pharmacother; 2011 Feb; 45(2):e11. PubMed ID: 21266630
[TBL] [Abstract][Full Text] [Related]
2. Flagellate erythema induced by docetaxel.
Tallon B; Lamb S
Clin Exp Dermatol; 2008 May; 33(3):276-7. PubMed ID: 18201264
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel extravasation causing significant delayed tissue injury.
Raley J; Geisler JP; Buekers TE; Sorosky JI
Gynecol Oncol; 2000 Aug; 78(2):259-60. PubMed ID: 10926814
[TBL] [Abstract][Full Text] [Related]
4. Vesicant-type reaction due to docetaxel extravasation.
Ho CH; Yang CH; Chu CY
Acta Derm Venereol; 2003; 83(6):467-8. PubMed ID: 14690348
[No Abstract] [Full Text] [Related]
5. [Recall dermatitis caused by re-exposure to docetaxel following irradiation of the brain. Case report and review of the literature].
Giesel BU; Kutz GG; Thiel HJ
Strahlenther Onkol; 2001 Sep; 177(9):487-93. PubMed ID: 11591023
[TBL] [Abstract][Full Text] [Related]
6. Acute erythema and edematous skin reaction and ectropion following docetaxel in a patient with non-small cell lung cancer.
Kaya AO; Buyukberber S; Coskun U; Yildiz R; Ozturk B; Yaman E; Adisen E; Gureli M; Benekli M
Cutan Ocul Toxicol; 2008; 27(4):327-31. PubMed ID: 18828046
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients.
Sanna G; Pestrin M; Zafarana E; Biagioni C; Cavaciocchi D; Turner N; Di Leo A; Biganzoli L
Breast; 2013 Oct; 22(5):926-32. PubMed ID: 23707082
[TBL] [Abstract][Full Text] [Related]
8. [Absence of cutaneous complications following extravasation of pegylated liposomal doxorubicin].
Capitain O; Lortholary A
Presse Med; 2003 Jun; 32(23):1077. PubMed ID: 12910162
[No Abstract] [Full Text] [Related]
9. Docetaxel extravasation into the normal breast during breast cancer treatment.
El Saghir NS; Otrock ZK
Anticancer Drugs; 2004 Apr; 15(4):401-4. PubMed ID: 15057145
[TBL] [Abstract][Full Text] [Related]
10. Radiation recall dermatitis from docetaxel.
Piroth MD; Krempien R; Wannenmacher M; Zierhut D
Onkologie; 2002 Oct; 25(5):438-40. PubMed ID: 12415198
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel recall phenomenon at the site of previous drug extravasation.
Ley BD; Millán GG; Perez JS; Fraga J; Díez AG
Arch Dermatol; 2010 Oct; 146(10):1190-1. PubMed ID: 20956672
[No Abstract] [Full Text] [Related]
12. Cutaneous reaction associated with weekly docetaxel administration.
Chew L; Chuen VS
J Oncol Pharm Pract; 2009 Mar; 15(1):29-34. PubMed ID: 18753180
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report.
Wong NY; Parsons LM; Trotter MJ; Tsang RY
BMC Res Notes; 2014 Nov; 7():785. PubMed ID: 25369825
[TBL] [Abstract][Full Text] [Related]
14. Safe administration of docetaxel after weekly paclitaxel-induced acute pancreatitis.
Adam JP; Gauthier P; Letarte N
J Oncol Pharm Pract; 2017 Oct; 23(7):540-544. PubMed ID: 27466225
[TBL] [Abstract][Full Text] [Related]
15. Radiation recall dermatitis induced by edatrexate in a patient with breast cancer.
Perez EA; Campbell DL; Ryu JK
Cancer Invest; 1995; 13(6):604-7. PubMed ID: 7583710
[TBL] [Abstract][Full Text] [Related]
16. Local erythematous dermatitis after intravenous docetaxel.
Hirai K; Ishiko O; Nakajima S; Kanaoka Y; Nakamura Y; Oiso N; Ishii M; Ogita S
Gynecol Obstet Invest; 2002; 53(2):118-20. PubMed ID: 11961387
[TBL] [Abstract][Full Text] [Related]
17. [Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].
Yuan P; Xu BH; Wang JY; Ma F; Li Q; Zhang P; Fan Y; Li Q; Wang WM
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):465-8. PubMed ID: 22967451
[TBL] [Abstract][Full Text] [Related]
18. Extravasation of docetaxel.
Cifuentes L; Ring J; Brockow K
J Dtsch Dermatol Ges; 2012 Sep; 10(9):662-3. PubMed ID: 22734918
[No Abstract] [Full Text] [Related]
19. Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active therapeutic regimens.
Valero V; Forbes J; Pegram MD; Pienkowski T; Eiermann W; von Minckwitz G; Roche H; Martin M; Crown J; Mackey JR; Fumoleau P; Rolski J; Mrsic-Krmpotic Z; Jagiello-Gruszfeld A; Riva A; Buyse M; Taupin H; Sauter G; Press MF; Slamon DJ
J Clin Oncol; 2011 Jan; 29(2):149-56. PubMed ID: 21115860
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous recall phenomenon at the site of previous doxorubicin extravasation after second-line chemotherapy.
Valencak J; Troch M; Raderer M
J Natl Cancer Inst; 2007 Jan; 99(2):177-8. PubMed ID: 17228004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
